tirzepatide weight loss efficacy vs semaglutide outperformed weight-loss drug results in real world patients, study shows Semaglutide vs Tirzepatide for Weight
Description
CAS : 2023788-19-2
Both medications work best with continued use
Some people at maintenance doses can eat small amounts of previously problematic foods without issues
Another important detail is that the GIP component may help improve tolerability for some patients compared to older GLP-1 medications alone
However, averages do not predict every patients outcome
A patient with T2D, obesity, and HF, for example, would be an ideal candidate for dual therapy with Tirzepatide and an SGLT2 inhibitor to address all aspects of their cardiometabolic-renal disease
